ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
+16.76%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$234M
AUM Growth
+$234M
Cap. Flow
-$55.9M
Cap. Flow %
-23.93%
Top 10 Hldgs %
58.55%
Holding
51
New
5
Increased
8
Reduced
20
Closed
14

Top Buys

1
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
$5.94M
2
ALGS icon
Aligos Therapeutics
ALGS
$4.37M
3
GHRS icon
GH Research
GHRS
$3.26M
4
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
$3.01M
5
APLS icon
Apellis Pharmaceuticals
APLS
$2.99M

Top Sells

1
ETNB icon
89bio
ETNB
$9.32M
2
CRIS icon
Curis
CRIS
$8.69M
3
TRIL
Trillium Therapeutics Inc.
TRIL
$7.11M
4
MRSN icon
Mersana Therapeutics
MRSN
$5.79M
5
ALT icon
Altimmune
ALT
$5.75M

Sector Composition

1 Healthcare 93.7%
2 Financials 6.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GHRS icon
26
GH Research
GHRS
$870M
$3.26M 1.3%
+150,000
New +$3.26M
ACRS icon
27
Aclaris Therapeutics
ACRS
$223M
$3.07M 1.23%
175,000
-142,730
-45% -$2.51M
GYRE icon
28
Gyre Therapeutics
GYRE
$734M
$2.97M 1.19%
685,000
-254,500
-27% -$1.1M
SAGE
29
DELISTED
Sage Therapeutics
SAGE
$2.89M 1.16%
50,945
-67,555
-57% -$3.84M
RAIN
30
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.52M 1.01%
+162,245
New +$2.52M
ATXS icon
31
Astria Therapeutics
ATXS
$394M
$2.48M 0.99%
+1,173,674
New +$2.48M
CPRX icon
32
Catalyst Pharmaceutical
CPRX
$2.42B
$1.89M 0.76%
329,134
+251,134
+322% +$1.44M
RNA icon
33
Avidity Biosciences
RNA
$6.12B
$1.48M 0.59%
60,000
-22,000
-27% -$544K
RETA
34
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.42M 0.57%
10,000
-4,000
-29% -$566K
CBAY
35
DELISTED
Cymabay Therapeutics
CBAY
$1.32M 0.53%
301,904
-13,437
-4% -$58.6K
NVAX icon
36
Novavax
NVAX
$1.2B
$491K 0.2%
2,315
-821
-26% -$174K
NUVB.WS icon
37
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$236K 0.09%
90,832
-2,500
-3% -$6.5K
VINCW
38
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
– –
-520,000
Closed -$2.1M
TRIL
39
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-661,565
Closed -$7.11M
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-9,000
Closed -$1.54M
STOK icon
41
Stoke Therapeutics
STOK
$1.08B
– –
-45,000
Closed -$1.75M
RAPT icon
42
RAPT Therapeutics
RAPT
$187M
– –
-200,289
Closed -$4.45M
PRAX icon
43
Praxis Precision Medicines
PRAX
$980M
– –
-154,229
Closed -$5.05M
PMVP icon
44
PMV Pharmaceuticals
PMVP
$82.1M
– –
-13,856
Closed -$456K
MRSN icon
45
Mersana Therapeutics
MRSN
$34.8M
– –
-357,689
Closed -$5.79M
INSM icon
46
Insmed
INSM
$30.3B
– –
-42,500
Closed -$1.45M
FDMT icon
47
4D Molecular Therapeutics
FDMT
$302M
– –
-20,000
Closed -$868K
ETNB icon
48
89bio
ETNB
$1.37B
– –
-393,548
Closed -$9.32M
CRIS icon
49
Curis
CRIS
$21.5M
– –
-767,500
Closed -$8.69M
CMPS
50
Compass Pathways
CMPS
$452M
– –
-90,000
Closed -$3.31M
1
2
3